By activating the Nrf2 pathway, it disrupts iron accumulation, lipid peroxidation, and ferroptosis, preventing the downregulation of GSH and GPX4 levels, thus ameliorating cisplatin-induced AKI (183). The gene discussed is GPX4; the disease is acute kidney injury.